logo
Obese and want to lose weight? Wegovy is not the long-term answer, according to leading weight loss surgeon

Obese and want to lose weight? Wegovy is not the long-term answer, according to leading weight loss surgeon

Economic Times12-07-2025
Getty Images
Doctor warns that Wegovy may cause weight regain without lifestyle changes. (Representative Image)
A leading New Zealand bariatric surgeon has warned that Wegovy, a newly available weight-loss drug that regulates your appetite and contains semaglutide, is not a standalone solution to obesity and could prove harmful without proper support.
Dr Rowan French, a Waikato-based bariatric surgeon, said the drug, recently made available in New Zealand, may trigger initial weight loss, but long-term results depend heavily on accompanying lifestyle changes.
Also Read: What happens near the Sun? NASA's Parker probe sends closest-ever photos of the Sun, unveils space weather origins'People need to know that it's likely, particularly for someone who's living with severe obesity... their problem is a lifelong one,' Dr French told RNZ. 'While it can be controlled, there's a good chance they will never fully be cured of that.'
Wegovy contains semaglutide, a synthetic version of a gut hormone (GLP-1) that regulates insulin and appetite. While it mimics some effects seen after bariatric surgery, such as reduced hunger, it is delivered via weekly injections into the systemic bloodstream rather than through natural gut pathways. French explained that this difference, combined with the way the body builds tolerance to GLP-1 (a phenomenon called tachyphylaxis), means the drug may lose its effectiveness faster than surgery.
'In other words, as time goes on, the patient will get less and less benefit from the medication,' he said. 'Any suggestion some people should stay on it for life is unlikely to be sensible or beneficial.'
He said that for weight-loss efforts using Wegovy or surgery to succeed, patients must address the psychological and behavioural roots of their eating habits. This includes understanding what triggers overeating and receiving nutritional counselling.'Without external help to understand their drivers to eat and nutritional help to understand the sorts of foods they should be eating — particularly in the first 18–24 months — the medications could prove more harmful than good,' he said.
Also Read: Cheaper than eggs, healthier than meat; the superfood that could save your health and the planet, and we are skipping it The surgeon noted that many patients experience weight regain after initially losing weight on either medication or surgery, especially without proper follow-up. In the case of Wegovy, stopping the drug often results in regained weight. But even staying on it may not guarantee sustained results due to increasing drug tolerance.'We know that, when semaglutide is stopped, in most cases, weight is regained,' he said. 'But we can also predict that if a patient stays on it, they will develop tolerance, because this occurs with bariatric surgery, albeit later in the piece.'
French underscored that obesity should be treated as a chronic disease, often rooted in genetic, early life, and environmental factors. He explained that most people have a genetically determined weight 'set point,' which the body subconsciously defends.'Our primitive brain interprets weight loss from dieting as starvation and starts to fight back,' he said. 'That's why yo-yo dieting often results in regaining more weight than was initially lost.'This process, he added, can raise an individual's set point over time, making long-term weight control increasingly difficult without medical intervention and behavioural support.
Also Read: Men posing as women to get nudes; what's the creepy new catfish trend on OnlyFans?
Another major factor driving obesity, French said, is the rise of ultra-processed foods (UPFs), which he described as 'manufactured to make us eat as much as possible.''These foods make up about 50–60 percent of what we eat now,' he said. 'We know from robust data that they cause metabolic disease, depression, dementia, and even cancer.'He urged patients to focus on eating whole foods 'at least 95 percent of the time,' describing them as items 'your grandma would recognise as food.'French warned that media and celebrity portrayals of Wegovy as a 'miracle drug' may be misleading. While the medication is a powerful tool, he said, it must be part of a comprehensive, multidisciplinary approach involving psychology, nutrition, and exercise.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Punjab: Muktsar hospital, doctor, insurer to pay student ₹22 lakh over medical negligence
Punjab: Muktsar hospital, doctor, insurer to pay student ₹22 lakh over medical negligence

Hindustan Times

time39 minutes ago

  • Hindustan Times

Punjab: Muktsar hospital, doctor, insurer to pay student ₹22 lakh over medical negligence

The district consumer disputes redressal commission (DCDRC) in Faridkot has directed a Muktsar-based doctor, hospital and an insurance firm to pay ₹22 lakh compensation to a youth for medical negligence that led to loss of his bright career opportunities abroad. The doctor and the hospital have rubbished the allegations levelled by the complainant, terming his plea an ulterior motive to extract money from them. According to commission president Rakesh Kumar Singla and member Param Pal Kaur's July 23 verdict, Dr Sandeep Singh Sandhu, Sandhu Hospital and Oriental Insurance Company Limited have to comply within 45 days of receipt of a copy of the order. As per rules, the accused can challenge the ruling before the state panel. Gurpreet Singh of Shaheed Balwinder Singh Nagar in Faridkot town had filed a complaint on February 10, 2021, against the three, seeking a compensation of ₹40 lakh. He stated that he was studying in New Zealand to pursue a diploma in 'Business Level 5' after paying a fee of NZ$16,100 for one year starting November 26, 2018. His petition stated that he flew to India on January 1, 2019, to meet his parents when he complained of abdominal pain and was taken to Dr Sandeep, who advised an ultrasound test that reportedly showed a suspicion calculus measuring 5-6 mm in his gallbladder's fundus. He was suggested for laser surgery. After another ultrasound test, the doctor allegedly recommended cholecystectomy, surgical intervention to remove the gallbladder. In their replies before the commission, the doctor and the hospital stated that during an intraoperative procedure, a rare complication was identified and another surgery was done following which Gurpreet complained of swelling in the abdomen and he was taken to a private hospital in Ludhiana. They also rubbished the allegations levelled by the complainant, terming his plea an ulterior motive to extract money from them. After hearing both parties, the commission found the charges of medical negligence true. The order stated that 'no discharge summary has been brought on record by the treating doctor to verify the fact that what procedure was adopted by the doctor and the hospital in treating the patient. There is nothing on record what kind of advice or instructions were given to the complainant regarding his medication and for follow-up. They have not placed on record a consent form showing the signatures of the complainant or his parents, which was mandatory before doing any surgery.' The order also mentioned that there is no record of the review ultrasound that confirms the diagnosis of gallstones and the surgery for suspicious gallstones is not justified. When Gurpreet was referred to a medical institute, no record of medical care or any relevant investigations conducted on him on that day was provided.

HC directs state govt to take steps to resume liver transplants in SCB
HC directs state govt to take steps to resume liver transplants in SCB

Time of India

time7 hours ago

  • Time of India

HC directs state govt to take steps to resume liver transplants in SCB

Cuttack: Orissa high court has directed the state govt to take urgent steps to resume liver transplant surgeries at SCB Medical College and Hospital (SCBMCH), Cuttack. The surgeries have been halted since April following the expiry of an MoU with a Hyderabad-based institute. Tired of too many ads? go ad free now In an order on July 31, the division bench comprising Justices S K Sahoo and V Narasingh said liver transplants are "crucial and cannot be deferred indefinitely". It directed the govt to provide a timeline for approval of a new partnership and resumption of transplants. The court was hearing a matter related to the discontinuation of transplants at SCB. Additional director of medical education and training and nodal officer for organ transplant, Dr Umakant Satapathy, informed the court via video link that a proposal for an MoU with MGM Healthcare, Chennai, for 30 liver transplants is pending with the govt. Taking note of the submission, the court asked the state to explore continuing the earlier arrangement with the Asian Institute of Gastroenterology (AIG), Hyderabad, to avoid any disruption in patient care. The bench directed the govt to file an affidavit by Tuesday, detailing how many patients are currently awaiting liver transplants, how many applications have been disposed of in the past three months, and minutes of SCB's authorisation committee meetings over the past six months. The next hearing is scheduled for Aug 7. On July 18, the HC had taken suo motu cognisance of a report published in a vernacular daily stating that liver transplants at SCB had come to a halt after the agreement with AIG expired on April 1. State govt had signed the MoU in 2022 to operationalise a liver transplant unit, which was officially launched in 2023 with Rs 22 crore sanctioned for infrastructure and logistics. Only two transplants have been conducted under the programme so far — the first on April 3, 2024, and the second on Sept 9, 2024. The initiative was designed to offer the high-cost procedure free of charge to eligible patients. With SCB lacking a fully trained in-house transplant team, the continuation of the programme remains uncertain unless a new partnership is secured soon.

11 free paediatric heart surgeries performed by Andhra Hospitals
11 free paediatric heart surgeries performed by Andhra Hospitals

The Hindu

time10 hours ago

  • The Hindu

11 free paediatric heart surgeries performed by Andhra Hospitals

The 35th Paediatric Cardiac Surgical Camp organised by the Heart and Brain Institute of Andhra Hospitals in association with a team from UK-based Healing Little Hearts concluded on Saturday (August 2, 2025). The camp commenced on July 28. At a press conference on Sunday (August 3, 2025), Chief of Children's Services and Director of the Hospital Dr. P. V. Rama Rao said that consultant paediatric cardiac surgeon Dr B. R. Jagannath from Shri Madhusudan Sai Hospital at Muddenahalli in Bengaluru along with Andhra Hospitals cardiac surgical team led by Dr. Nageswara Rao, completed 11 free heart surgeries. The team performed very complex heart surgeries for conditions like Total Anomalous Pulmonary Venous Drainage (TAPVD), Partial Anomalous Pulmonary Venous Drainage (PAPVD), TOF and PA banding among other surgeries, he said, adding that the success rate of the surgeries was nearly 99% and which is because of the team effort. He said so far, the hospital had successfully performed more than 4,800 cardiac surgeries and interventions. Representatives of the Healing Little Hearts, UK team, have visited the hospital 34 times so far and many complex heart surgeries were performed with their association, he added. Senior paediatric cardiologist Dr. Vikram, Paediatric cardiologist Dr. Sk. Moinuddin Chisty, senior cardiac surgeon Dr. Nageswara Rao, senior cardiac anaesthetist Dr. Ramesh and cardiologists Dr. Raghuram, and Dr. Tirupathi Rao were also present at the press meet.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store